| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0004 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |